Rossing P, Benamar M, Cheng A, Kumar B, Laugesen C, Bajaj H
Diabetes Obes Metab. 2025; 27(4):2259-2270.
PMID: 39930546
PMC: 11885089.
DOI: 10.1111/dom.16231.
Alzahrani M, AlAbdan N, Alahmari Z, Alshehri N, Alotaibi L, Almohammed O
J Clin Med. 2024; 13(17).
PMID: 39274318
PMC: 11396335.
DOI: 10.3390/jcm13175103.
Shibib L, Al-Qaisi M, Guess N, Miras A, Greenwald S, Pelling M
Diabetes Metab Syndr Obes. 2024; 17:3111-3130.
PMID: 39206417
PMC: 11350065.
DOI: 10.2147/DMSO.S458894.
Habte-Asres H, Jiang Y, Rosenthal M, Wheeler D
BMJ Open Diabetes Res Care. 2024; 12(1).
PMID: 38302432
PMC: 10836342.
DOI: 10.1136/bmjdrc-2023-003730.
Kim J, Han J, Yun B, Yee J, Gwak H
Hormones (Athens). 2023; 22(4):637-645.
PMID: 37755659
DOI: 10.1007/s42000-023-00492-0.
Use of Second-Generation Basal Insulin Gla-300 in Special Populations: A Narrative Mini-Review.
Ghosh S, Kalra S, Bantwal G, Sahay R
Curr Diabetes Rev. 2023; 19(9):e090123212447.
PMID: 36624651
PMC: 10617786.
DOI: 10.2174/1573399819666230109113205.
Frequency of Adrenal Insufficiency in Patients With Hypoglycemia in an Emergency Department: A Cross-sectional Study.
Kawahara T, Tsuji M, Tominaga N, Toyama N, Toda M
J Endocr Soc. 2022; 6(10):bvac119.
PMID: 36042975
PMC: 9419498.
DOI: 10.1210/jendso/bvac119.
Interconnection between cardiovascular, renal and metabolic disorders: A narrative review with a focus on Japan.
Kadowaki T, Maegawa H, Watada H, Yabe D, Node K, Murohara T
Diabetes Obes Metab. 2022; 24(12):2283-2296.
PMID: 35929483
DOI: 10.1111/dom.14829.
Insulin use in chronic kidney disease and the risk of hypoglycemic events.
Grube D, Wei G, Boucher R, Abraham N, Zhou N, Gonce V
BMC Nephrol. 2022; 23(1):73.
PMID: 35189851
PMC: 8862360.
DOI: 10.1186/s12882-022-02687-w.
The risk factors and predictive nomogram of human albumin infusion during the perioperative period of posterior lumbar interbody fusion: a study based on 2015-2020 data from a local hospital.
Liu B, Pan J, Zong H, Wang Z
J Orthop Surg Res. 2021; 16(1):654.
PMID: 34717707
PMC: 8557501.
DOI: 10.1186/s13018-021-02808-5.
Impact of kidney function on the safety and efficacy of insulin degludec versus insulin glargine U300 in people with type 2 diabetes: A post hoc analysis of the CONCLUDE trial.
Pieber T, Bajaj H, Heller S, Jia T, Khunti K, Klonoff D
Diabetes Obes Metab. 2021; 24(2):332-336.
PMID: 34605127
PMC: 9298323.
DOI: 10.1111/dom.14564.
Screening, prevalence, treatment and control of kidney disease in patients with type 1 and type 2 diabetes in low-to-middle-income countries (2005-2017): the International Diabetes Management Practices Study (IDMPS).
Mbanya J, Aschner P, Gagliardino J, Ilkova H, Lavalle F, Ramachandran A
Diabetologia. 2021; 64(6):1246-1255.
PMID: 33594476
PMC: 8099838.
DOI: 10.1007/s00125-021-05406-6.
Sudden Death Associated with Severe Hypoglycemia in a Diabetic Patient During Sensor-Augmented Pump Therapy with the Predictive Low Glucose Management System.
Nishihama K, Eguchi K, Maki K, Okano Y, Tanaka S, Inoue C
Am J Case Rep. 2021; 22:e928090.
PMID: 33462171
PMC: 7823147.
DOI: 10.12659/AJCR.928090.
Incidence and risk factors associated with hypoglycemia among patients with chronic kidney disease: A systematic review.
Aleissa M, AlGhofaili I, Alotaibe H, Yaslam M, Almujil M, Arnous M
J Family Community Med. 2020; 27(3):157-162.
PMID: 33354145
PMC: 7745784.
DOI: 10.4103/jfcm.JFCM_304_19.
Impaired insulin secretion predicting unstable glycemic variability and time below range in type 2 diabetes patients regardless of glycated hemoglobin or diabetes treatment.
Miya A, Nakamura A, Handa T, Nomoto H, Kameda H, Cho K
J Diabetes Investig. 2020; 12(5):738-746.
PMID: 33021063
PMC: 8089015.
DOI: 10.1111/jdi.13426.
Differential glycaemic control with basal insulin glargine 300 U/mL versus degludec 100 U/mL according to kidney function in type 2 diabetes: A subanalysis from the BRIGHT trial.
Haluzik M, Cheng A, Muller-Wieland D, Westerbacka J, Bosnyak Z, Lauand F
Diabetes Obes Metab. 2020; 22(8):1369-1377.
PMID: 32243043
PMC: 7383874.
DOI: 10.1111/dom.14043.
First-trimester blood urea nitrogen and risk of gestational diabetes mellitus.
Feng P, Wang G, Yu Q, Zhu W, Zhong C
J Cell Mol Med. 2020; 24(4):2416-2422.
PMID: 31925909
PMC: 7028843.
DOI: 10.1111/jcmm.14924.
Optimizing Postprandial Glucose Management in Adults With Insulin-Requiring Diabetes: Report and Recommendations.
Leahy J, Aleppo G, Fonseca V, Garg S, Hirsch I, McCall A
J Endocr Soc. 2019; 3(10):1942-1957.
PMID: 31608313
PMC: 6781941.
DOI: 10.1210/js.2019-00222.
Effectiveness and safety of sotagliflozin adjuvant therapy for type 1 diabetes mellitus: A protocol for Systematic review and Meta-analysis.
Chen M, Xu R, Zheng Q, Zheng X, Wang H, Ding Y
Medicine (Baltimore). 2019; 98(33):e16850.
PMID: 31415414
PMC: 6831156.
DOI: 10.1097/MD.0000000000016850.
Efficacy and safety of trelagliptin in Japanese patients with type 2 diabetes with severe renal impairment or end-stage renal disease: Results from a randomized, phase 3 study.
Kaku K, Ishida K, Shimizu K, Achira M, Umeda Y
J Diabetes Investig. 2019; 11(2):373-381.
PMID: 31389201
PMC: 7078116.
DOI: 10.1111/jdi.13126.
